Clinical Trials, Drug Manufacturers, Technology, Therapy Area

Stability Tests According to ICH Q1A (R2)

By Memmert

In 1990, the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) was born. This paper summarises the main contents of Guideline ICH Q1A (R2), which deals with the stability testing of new drug products and new drug substances.

The first part describes the general objectives of stability tests, the second part deals specifically with stability tests according to ICH Q1A (R2). Most of the stability samples are stored under standard climates. The third part of the paper therefore describes the most important requirements for a GMP-compliant climate chamber. In the last part, stability and climate tests from other industries are presented.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Sections

Sections

Sections

Sections

Sections